電話

Consultation Info.:049-228-3411

Number Info.:049-228-3400

▶Contact information

Outpatient Chemotherapy Center

October 26,2020 Update

Introduction

Treatment with anti-cancer drugs is one of the three major treatments for cancer, along with surgery and radiation. In recent years, the development of new anti-cancer drugs, the combination of effective anti-cancer drugs and the advancement of support therapy to reduce side effects has made it possible for patients to undergo anti-cancer treatment as an outpatient while still maintaining their conventional lives.

In October 2006, an outpatient chemotherapy room was established at the Saitama Medical Center, aiming to provide high-quality anti-cancer drug treatment. In January 2007, it was designated as a Regional Cancer Treatment Cooperative Base Hospital and is working to provide standard cancer therapy and to strengthen medical cooperation with the local community. In June 2008, the number of beds increased from 7 to 15. In August 2017, it was opened as the Outpatient Chemotherapy Center after renewal with the number of beds expanded to 40 and was enhanced with respect to the functionality.

All of the Outpatient Chemotherapy Center staff, the doctors, nurses, and pharmacists are working together to make use of their expertise to provide safe medical care.

Outpatient Chemotherapy Center overview

Location Main building 3rd floor
Main equipment Reclining chairs: 38 beds (including 2 in a dark room) *All with TVs
Beds: 2 beds
Consultation rooms: 5 rooms
Other, wheelchair-accessible toilet, Ostomate available toilet
Times Monday to Saturday (except Sundays, national holidays and Year-end and New Year holidays) 8:30 to 17:30
Location
Location
Layout
Layout
Reclining chair
Reclining chair
Bed
Bed

Staff introduction

One full-time physician, and doctors in charge of other departments
Nurses: 19 people
Pharmacists: 9 people
Management registered dietitian: 1 people

Main staff (As of September 2020)
Dcotor Hideyuki Ishida Department of Digestive Tract and General Surgery,Surgeon in Chief,Professor
Board Certified Surgeon (Jpn Surg Association, Jpn Soc Gastroenterol Surg)
Board Certified Physician (Jpn Soc Coloproctol)
General Clinical Oncologist (by JBCT)
Faculty(tentative), Subspecialty Board of Medical Oncology, JSMO
Nurse Teruko Ando Head Nurse
Certified Nurse Administrator
Nurse Yumi Anazawa Chief
Certified Nurse in Palliative Care
Nurse Hiromi Shimada Certified Nurse in Cancer Chemotherapy Nursing
Pharmacist Hiroyuki Ooya Chief
Board Certified Pharmacist in Palliative Pharmacy(BCPPP)
Pharmacist Yoshimi Shimada Chief
JSCN Supplement Adviser
Pharmacist Mashu Morimoto JASPO Accredited Pharmacist of Ambulatory Cancer Chemotherapy(APACC)
JSPEN Certificated Pharmacist in Nutritional Support
Management registered dietitian Miho Oonisi JSMCN Cancer Pathology Nutrition Specialized Registered Dietitian
JSMCN Pathology Nutrition Certified Registered Dietitian
JSPEN Certificated Dietitian in Nutritional Support
JSMCN NST Coordinator
Saitama Prefecture Hepatitis Coordinator

Flow of a consultation

The flow from reception to the examination and the treatment at the Outpatient Chemotherapy Center and accounting is as shown below. All the staff are involved with the patient, from coming in to the clinic to going home.

診療の流れ

Medical Service Content

Outpatient Chemotherapy Center features

  1. We can also treat them with biological preparations for rheumatoid arthritis and inflammatory bowel diseases in addition to treatment with anticancer drugs.
  2. Various types of cancers can be treated with anti-cancer drugs, and they are treated with not only cytotoxic anti-cancer drugs and molecular target therapeutics, but also with immune checkpoint inhibitors.
  3. We practice team medical care with doctors, nurses, pharmacists and other medical practitioners, from the time the patient comes in until they go home.

There are 14 medical departments that utilize the Outpatient Chemotherapy Center, and 336 types of registered treatments (regimens) (Table 1). All of them are standard treatment methods that have been registered after specialists from multiple medical departments evaluated the validity of the treatment.

The target diseases include colon cancer, gastric cancer, lung cancer, breast cancer, pancreatic cancer, ovarian cancer, uterine body cancer, cervical cancer, malignant lymphoma, and multiple myeloma. The details for the results of the medical treatment are listed (Table 2).

We have prepared a patient brochure with the most commonly used regimens (Figure 1). This brochure contains the schedule of treatments, the type of infusions on the day of treatment, the order of administration, the time required, the type and timing of the major side effects, home care and life advice, and emergency contact information. We also create a patient journal (Figure 2) and a pamphlet for each side effect (Figure 3) to help patients understand the treatment and the side effects, and to continue the safe treatment at their hospital visits. In August 2008, we opened a consultation desk called the "Cancer Treatment and Pain Counseling Room" in order to respond to the discomfort of the physical symptoms and feelings such as the pain caused by cancer, the anxiety associated with treatment, and the worries about life and care at home. Here, we work with the palliative care team to provide consultation for the patients and their families.

Table 1. Outpatient Chemotherapy Center therapy regimen count
Department of Gastroenterology and Hepatology 23
Department of Digestive Tract and General Surgery 54
Department of Hepato-Biliary-Pancreatic and Pediatric Surgery 15
Department of Pulmonary Medicine 39
Department of General Thoracic Surgery 40
Department of Hematology 43
Department of Obstetrics and Gynecology 37
Department of Breast Care 40
Department of Urology 19
Department of Neurosurgery 5
Department of Dermatology 7
Department of Rheumatology and Clinical Immunology 10
Department of Pediatrics 3
Department of Neurology 1
Total (As of September 2020) 336
Figure 1. Brochure for explanation to the patients
Brochure for explanation to the patients
Figure 2. Patient diary
Patient journal
Figure 3. Pamphlets for each adverse event
Pamphlets for each side effect

Treatment results

(1) Transitions and number of uses
変遷と利用件数の推移

(2) Table 2.2019 results

Malignant tumors Cases
Breast cancer 1587
Lung cancer 1509
Colon cancer 1153
Malignant lymphoma 834
Stomach cancer 621
Pancreatic cancer 608
Myelodysplastic syndromes 409
Ovarian cancer 397
Multiple myeloma 310
Biliary tract cancer and bile duct cancer 289
Renal cell cancer 235
Urothelial cancer 234
Uterine body cancer 202
Prostate cancer 137
Cervical cancer 129
Malignant melanoma 109
Malignant glioma 62
Esophageal cancer 37
Other 129
Other than malignant tumors Cases
Articular rheumatism 1679
Crohn’s disease 413
Ulcerative colitis 230
Bechet’s disease 75
Psoriasis 74
Granulomatosis with polyangiitis/microscopic polyangiitis 37
Systemic-onset juvenile idiopathic arthritis 28
Ankylosing spondylitis 16
Castleman disease 15
Thrombotic thrombocytopenic purpura 2
Other rheumatic disease 3

To the Medical Institutions

All of our staff are working hard daily to provide safe and high quality medical care for our patients. If you have any questions, please contact the doctor in charge of each department or the Outpatient Chemotherapy Center staff.

Tel. 049-228-3599 (Outpatient Chemotherapy Center reception)
Monday to Saturday (except Sundays, national holidays and Year-end and New Year holidays)
From 8:30 to 17:30

埼玉医科大学バナー 埼玉医科大学看護学校バナー